PDL1 Detection Set (Risk Free), IgG1, Unconjugated, Mouse, Monoclonal

Catalog Number: PRS-RF16030
Article Name: PDL1 Detection Set (Risk Free), IgG1, Unconjugated, Mouse, Monoclonal
Biozol Catalog Number: PRS-RF16030
Supplier Catalog Number: RF16030
Alternative Catalog Number: PRS-RF16030-1
Manufacturer: ProSci
Host: Mouse
Category: Antikörper
Application: ELISA, FC, ICC, IF, IHC-P, WB
Species Reactivity: Human
Immunogen: PD-L1 antibodies were raised against the extracellular domain of human PD-L1.
Conjugation: Unconjugated
Clonality: Monoclonal
Concentration: Antibody 1 mg/mL
Isotype: IgG1
Buffer: PBS containing 0.02% sodium azide.
Form: Liquid
Application Dilute: Optimal dilutions for each application to be determined by the researcher.
Flow cytometry analysis of PD-L1 in over expressing HEK293 cells using (A) RF16031, (B) RF16032, (C) RF16033, and (D) mouse IgG at 0.1 &956,g/ml. Blue: untransfected HEK293 cells. Yellow: PD-L1 over expressing HEK293 cells.
Immunocytochemistry of PD-L1 in over expressing HEK293 cells using (A) RF16031, (B) RF16032, (C) RF16033, (D) RF16035, (E) RF16036, (F) RF16037, (G) RF16038, and (H) control mouse IgG antibody at 1 &956,g/ml.
Immunofluorescence of PD-L1 in over expressing HEK293 cells using (A) RF16031, (B) RF16032, (C) RF16033, (D) RF16035, (E) RF16036, (F) RF16037, and (G) RF16038 antibody at 2 &956,g/ml.
Immunofluorescence of PD-L1 in human stomach carcinoma tissue using (A) RF16031, (B) RF16032, (C) RF16033, (D) RF16035, (E) RF16036, (F) RF16037, and (G) RF16038 antibody at 2 &956,g/ml.
Immunohistochemistry of PD-L1 in human stomach carcinoma tissue using (A) RF16031, (B) RF16032, (C) RF16033, (D) RF16035, (E) RF16036, (F) RF16037, (G) RF16038, and (H) control mouse IgG antibody at 10 &956,g/ml.
Western blot analysis of PD-L1 in over expressing HEK293 cells using RF16031, RF16032, RF16035, RF16036, RF16037, and RF16038 antibodies at 0.25 &956,g/ml and 0.5 &956,g/ml.
Titration curve analysis of PD-L1 mAbs to detect recombinant PD-L1 in ELISA with RF16031, RF16032, RF16033, RF16035, RF16036, RF16037, and RF16038 antibodies at decreasing concentrations.